Desk Report
Publish: 08 Sep 2021, 06:56 pm
Indian High Commissioner Vikram Kumar Doraiswami || Photo: Collected
The
Serum Institute of India would shortly begin the export of Covid-19 vaccine to
Bangladesh, said Indian High Commissioner to Bangladesh, Vikram Kumar
Doraiswami on Wednesday (Sept 8).
"Vaccine
production has increased in India. Hopefully, just as the export of oxygen has
started, the export of vaccines will also start soon," he said.
Indian
High Commissioner Vikram Kumar Doraiswami made the remarks while talking to
media at the Akhaura International Immigration Check-post.
In
response to a question about Indian tourist visas, Doraiswami stated that the
resumption of accepting tourist permits to visit India is contingent on the
Covid-19 situation.
Due
to an internal crisis, India had previously imposed a ban on the export of
life-saving vaccines.
The
Bangladesh government was supposed to get 50 lakh doses of Oxford-AstraZeneca
Covid-19 vaccine every month as part of an agreement with India's Serum
Institute and Beximco.
Under
the terms of the agreement, Bangladesh has received 70 lakh doses in two shipments.
On
January 25, the first shipments of 50 lakh doses of Oxford vaccine arrived in Dhaka
from India.
On
February 22, the second batch of 20 lakh medicines arrived.
Subscribe Shampratik Deshkal Youtube Channel
Topic : Serum Institute Vaccine
© 2024 Shampratik Deshkal All Rights Reserved. Design & Developed By Root Soft Bangladesh